IGM BIOSCIENCES INC (IGMS) Earnings History & Surprises
NASDAQ:IGMS • US4495851085
1.27 USD
-0.03 (-2.31%)
At close: Aug 13, 2025
1.28 USD
+0.01 (+0.79%)
After Hours: 8/13/2025, 8:15:46 PM
Past quarterly earnings results for IGM BIOSCIENCES INC (IGMS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateNov 6, 2025
PeriodQ3 / 2025
EPS Estimate-$0.31
Revenue Estimate3.277M
Last Reported
Release DateJul 31, 2025
PeriodQ2 / 2025
EPS Reported$1.58
EPS Surprise 616.34%
Revenue Surprise 4,296.17%
Beat Rate
50%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | 1.58 | -0.31 | 616.34% | 300.00% | 143.623M | 3.267M | 4,296.17% | 11,353.19% |
| Q1 2025 | -0.51 | -0.42 | -21.95% | 38.55% | 499K | 3.164M | -84.23% | 0.40% |
| Q4 2024 | -0.61 | -0.75 | 18.96% | 39.60% | 412K | 401.625K | 2.58% | -36.71% |
| Q3 2024 | -1.01 | -0.82 | -23.77% | 2.88% | 516K | 272.564K | 89.31% | 1.38% |
| Q2 2024 | -0.79 | -0.04 | -1,950.05% | 44.76% | 1.254M | 55.399M | -97.74% | 179.91% |
| Q1 2024 | -0.83 | -0.85 | 2.12% | 37.59% | 497K | 774.568K | -35.84% | -4.79% |
| Q4 2023 | -1.01 | -1.05 | 4.11% | 15.13% | 651K | 716.173K | -9.10% | 75.95% |
| Q3 2023 | -1.04 | -1.24 | 15.94% | 21.21% | 509K | 829.036K | -38.60% | 54.24% |
| Q2 2023 | -1.43 | -1.46 | 2.23% | -7.52% | 448K | 813.552K | -44.93% | 21.08% |
| Q1 2023 | -1.33 | -1.39 | 4.39% | 13.07% | 522K | 1.677M | -68.87% | - |
| Q4 2022 | -1.19 | -1.27 | 6.39% | 20.67% | 370K | 307.275K | 20.41% | - |
| Q3 2022 | -1.32 | -1.45 | 9.27% | - | 330K | 258.172K | 27.82% | - |
| Q2 2022 | -1.33 | -0.96 | -38.72% | -14.66% | 370K | 27.413M | -98.65% | - |
| Q1 2022 | -1.53 | -1.65 | 7.05% | -61.05% | - | - | ||
| Q4 2021 | -1.50 | -1.57 | 4.64% | -89.87% | - | - | ||
| Q3 2021 | -1.32 | -1.39 | 5.31% | -100.00% | - | - | ||
| Q2 2021 | -1.16 | -1.19 | 2.56% | -87.10% | - | - | ||
| Q1 2021 | -0.95 | -1.00 | 4.97% | -63.79% | - | - | ||
| Q4 2020 | -0.79 | -0.89 | 10.83% | - | - | - | ||
| Q3 2020 | -0.66 | -0.70 | 6.22% | - | - | - | ||
| Q2 2020 | -0.62 | -0.66 | 5.76% | - | - | - | ||
| Q1 2020 | -0.58 | -0.56 | -3.39% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
147.40%
Max EPS beat (4)
616.34%
Min EPS beat (4)
-23.77%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
1,075.96%
Max Revenue beat (4)
4,296.17%
Min Revenue beat (4)
-84.23%
Analysis
In the last 4 quarters, IGMS has beaten EPS estimates in 2 out of 4 releases
IGMS has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, IGMS has beaten the EPS estimates by 147.4% on average.
In the last 4 quarters, IGMS has beaten the revenue estimates by 1076.0% on average.
IGM BIOSCIENCES INC / IGMS Earnings FAQ
Can you provide the last earnings date for IGM BIOSCIENCES INC?
IGM BIOSCIENCES INC (IGMS) last reported earnings on 7/31/2025.
Can you provide information on whether IGM BIOSCIENCES INC beat earnings estimates in the last quarter?
IGM BIOSCIENCES INC (IGMS) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does IGM BIOSCIENCES INC (IGMS) beat earnings estimates?
In the last 4 quarters, IGM BIOSCIENCES INC (IGMS) has beaten EPS estimates in 2 out of 4 releases.